David Lamond is Director at Cortexyme, Inc. (CRTX). They have made 11 open-market trades across 3 companies since 2020, most recently 2023-12-14.
CIK 0001770790
11 open-market purchases totalling $17.5M since 2020, never a sale. Across 11 scored buys the stock is down 1.2% at ninety days, and 9.0 points behind the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 64% | 55% | 55% |
| Avg Move | -2.0% | +1.0% | -1.2% |
| Alpha | -4.4% | -1.0% | -9.0% |
| Scored | 11 | 11 | 11 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| QNCX | BUY | 2023-12-12 | 2023-12-14 | $1.02 | $69K | +5.7% | +29.2% | +11.3% |
| QNCX | BUY | 2023-12-05 | 2023-12-07 | $1.01 | $58K | +9.5% | +12.0% | +17.0% |
| QNCX | BUY | 2023-11-29 | 2023-12-01 | $0.94 | $41K | +2.7% | +7.7% | +34.6% |
| QNCX | BUY | 2023-08-30 | 2023-08-31 | $1.31 | $216K | -4.5% | -20.1% | -29.8% |
| QNCX | BUY | 2023-08-15 | 2023-08-17 | $1.30 | $620K | +0.8% | -3.1% | -31.5% |
| AMTI | BUY | 2022-05-20 | 2022-05-23 | $3.17 | $211K | +4.0% | +7.1% | -49.8% |
| AMTI | BUY | 2021-04-06 | 2021-04-07 | $42.00 | $1.1M | -29.7% | -19.6% | -22.3% |
| CRTX | BUY | 2021-03-24 | 2021-03-24 | $33.77 | $3.4M | +2.6% | +12.1% | +64.4% |
| CRTX | BUY | 2021-03-04 | 2021-03-05 | $35.32 | $2.9M | -7.3% | -10.7% | +13.7% |
| CRTX | BUY | 2020-06-04 | 2020-06-08 | $43.27 | $4.3M | +16.8% | +7.3% | +1.0% |
| CRTX | BUY | 2020-05-15 | 2020-05-19 | $55.64 | $4.7M | -23.1% | -11.1% | -21.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.